About
News and coverage
Announcements from Motagon and press coverage of the company.
-
Motagon receives EU-GMP Part I certification
July 2026, Motagon adds EU-GMP Part I for finished medicinal products to the Part II authorisation held since 2022.
-
Exclusive Curaleaf distribution in the Czech Republic
Motagon becomes the exclusive Czech distributor for Curaleaf medical cannabis products.
-
GPs can now prescribe medical cannabis for chronic pain
From 1 April 2025, general practitioners with specialities 001 and 002 may prescribe for diagnosis R52.1.
-
First Czech supply of full-spectrum cannabis extracts
Motagon becomes the first pharmaceutical company in the Czech Republic to supply medical cannabis extracts to patients.
Newsletter
Company news by email
Licence news, new products and batches, and events for healthcare professionals. A few emails a year, written by the team, and nothing promotional about prescription-only medicines to anyone who is not a healthcare professional.